Monograph: Bamlanivimab

Bamlanivimab

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Bamlanivimab

Generic Name

Bamlanivimab

INV Number

...

Classification

Introduction

Introduction

...

...

Description

...

Spectrum

...

Resistance

...

...

Uses

Uses

...

Coronavirus Disease 2019 (COVID-19)

...

Emergency Use Authorization (EUA)

...

Outpatients with Mild to Moderate COVID-19

...

Patients Hospitalized with COVID-19

...

...

Dosage and Administration

Dosage and Administration

...

General

...

Administration

...

IV Infusion

...

Rate of Administration

...

Dosage

...

Adult Dosage

...

Coronavirus Disease 2019 (COVID-19)

...

Pediatric Dosage

...

Coronavirus Disease 2019 (COVID-19)

...

Special Populations

...

Hepatic Impairment

...

Renal Impairment

...

Geriatric Patients

...

...

Cautions

Cautions

...

Contraindications

...

Warnings/Precautions

...

Sensitivity and Infusion-related Reactions

...

Limitations of Benefit and Potential for Risk in Patients with Severe COVID-19

...

EUA Requirements for Patient Monitoring and Mandatory FDA MedWatch Reporting

...

Specific Populations

...

Pregnancy

...

Lactation

...

Pediatric Use

...

Geriatric Use

...

Hepatic Impairment

...

Renal Impairment

...

Common Adverse Effects

...

...

Drug Interactions

Drug Interactions

...

...

Pharmacokinetics

Pharmacokinetics

...

Absorption

...

Distribution

...

Elimination

...

Special Populations

...

...

Stability Section

Stability

...

Solution Concentrate for Injection, for IV Infusion

...

...

Advice to Patients

Advice to Patients

...

...

Preparations

Preparations

...

Bamlanivimab

...

...

Common general statement Elements

Additional Information

...

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2020, Selected Revisions December 5, 2020. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

Quelle

AHFS Drug Information